Exact Sciences Corp
Abierto
SectorSanidad
104.93
Resumen
Variación precio
24h
Mínimo
104.9
Máximo
104.96
Ingresos | -66M -86M |
|---|---|
Ventas | 28M 878M |
BPA | -0.21 |
Margen de beneficios | -9.786 |
Empleados | 7,100 |
EBITDA | -68M -20M |
Recomendaciones | Neutral |
|---|---|
Estimación a 12 Meses | +0.09% upside |
Capitalización Mercado | 404M 20B |
|---|---|
Apertura anterior | 104.93 |
Cierre anterior | 104.93 |
Puntuación técnica
By Trading Central
Confianza
Strong Bullish Evidence
Exact Sciences Corp Gráfico
Resultados pasados no son un indicador fiable de resultados futuros.
Noticias Relacionadas
Comparación entre iguales
Cambio de precio
Exact Sciences Corp previsión
Precio Objetivo
By TipRanks
0.09% repunte
Estimación a 12 Meses
Media 105 USD 0.09%
Máximo 105 USD
Mínimo 105 USD
De acuerdo con 6 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Exact Sciences Corp Dist en los últimos 3 meses.
Finanzas
$
Acerca de Exact Sciences Corp
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX Breast Recurrence Score Test; Oncotype DX Breast DCIS Score Test; Oncotype DX Colon Recurrence Score Test; OncoExTra Test for tumor profiling for patients with advanced, metastatic, refractory, relapsed, or recurrent cancer; and Covid-19 testing services. The company's pipeline products focus on enhancing the Cologuard test's performance characteristics and developing blood and other fluid-based tests. It has license agreements with MAYO Foundation for Medical Education and Research, and Johns Hopkins University. Exact Sciences Corporation was incorporated in 1995 and is headquartered in Madison, Wisconsin.
